SLC22A5 and hepatitis B virus infection: OCTN2 is considered a target for improving the bioavailability of oral drug delivery [84], as it can influence the distribution and absorption of drugs in the lungs [85,86], anti-hepatitis B drugs in the liver [87], and the antibiotic colistin [88].